-
EZ Cap Cy5 Firefly Luciferase mRNA Workflow
2026-09-10
Build a dual-readout workflow that separates mRNA uptake from productive translation using Cy5 fluorescence and Firefly luciferase bioluminescence. This guide combines practical transfection optimization with carrier-tropism insights from a lung-targeting mRNA study.
-
Tunicamycin for ER Stress Research
2026-09-10
Tunicamycin is a practical N-glycosylation inhibitor for building controlled ER-stress models, from RAW264.7 macrophage inflammation assays to glioblastoma resistance studies. This guide translates its mechanism into dose-finding, multi-readout workflows and troubleshooting strategies centered on GRP78, UPR signaling, COX-2, iNOS and FKBP9 biology.
-
AO/PI Staining Solution in Kidney Cell Models
2026-09-09
Learn how AO/PI Staining Solution supports fluorescence-based cell counting in diabetic nephropathy models. This guide connects membrane-integrity measurements with the inflammatory and apoptotic mechanisms reported for phillygenin, while clarifying what the assay can and cannot prove.
-
RNA Pol II Inhibition and the PDAR Mechanism
2026-09-09
Harper and colleagues show that RNA Pol II inhibition kills cells through an active apoptotic pathway triggered by depletion of hypophosphorylated Rpb1, rather than through transcriptional failure alone. The study defines the Pol II degradation-dependent apoptotic response and uses functional genomics to connect nuclear Pol II loss with mitochondrial cell death, providing a framework for interpreting the activity of transcription-targeting therapies.
-
TRIM66 and Monogenic Olfactory Receptor Expression
2026-09-08
The reference study identifies TRIM66 as an epigenetic repressor that helps convert initially polygenic olfactory receptor expression into the mature one-neuron–one-receptor state. Genetic loss of Trim66 disrupts receptor selection, neural activity, and innate olfactory behavior, linking enhancer repression to sensory-circuit function.
-
N2703 in Cardiac Signaling Assays
2026-09-08
Explore how 3-(1-methylpyrrolidin-2-yl)pyridine (N2703) can support hypothesis-driven cardiac signaling assays without overstating its mechanism. This article translates the adipose-neural arrhythmia model into practical probe-selection, control, and interpretation strategies.
-
Mechanical Stress and Cytoskeleton-Dependent Autophagy
2026-09-07
The reference study provides direct evidence that cytoskeletal microfilaments are central to autophagy triggered by cellular compression, while microtubules contribute in an auxiliary manner. Its perturbation-based design links cytoskeletal organization with mechanotransduction and offers a framework for separating force sensing from downstream autophagy responses.
-
Fluoxetine HCl Workflows for Neuroscience Research
2026-09-07
Fluoxetine HCl enables concentration-aware studies of serotonin transport, 5-HT2C signaling, neuroplasticity, and reward behavior. This workflow connects molecular assays with developmental SSRI findings while showing how to separate motivation deficits from changes in reward liking or learning.
-
CAY10499: Inhibitor of Human Hormone Sensitive Lipase
2026-09-05
CAY10499 provides a quantitative way to perturb HSL, MGL, and related lipid signaling in enzyme assays, monocyte-to-macrophage models, and lipid-flux studies. Its strongest value is as an orthogonal lipid-metabolism probe for testing how EV-driven metabolic reprogramming relates to tumor-associated macrophage biology, not as a substitute for direct ACLY inhibition.
-
Coelenterazine for ROS Reporter Assays
2026-09-04
Coelenterazine connects coelenterate luciferase reporters with chemiluminescent detection of superoxide anion and peroxynitrite. This practical guide explains solvent handling, kinetic workflows, AVP-axis applications, cancer-associated ROS imaging, and controls that separate reporter activity from oxidative chemistry.
-
JC-1 Mitochondrial Membrane Potential Workflow
2026-09-04
Build a practical JC-1 mitochondrial membrane potential assay around ratiometric red-to-green fluorescence, controlled staining, and orthogonal apoptosis readouts. The workflow translates recent mechanistic findings in anaplastic thyroid cancer into actionable experiments for mitochondrial dysfunction research and drug-response profiling.
-
Prolonged Hypoxia Activates NLRP3 in Urothelium
2026-09-03
Hudson and colleagues show that hypoxic duration determines whether rat urothelial cells develop an inflammatory caspase-1 response. The study links prolonged enzyme-induced hypoxia to a ROS/TXNIP/NLRP3 pathway and provides a mechanistic framework for understanding how bladder outlet obstruction may promote chronic bladder inflammation.
-
ERK Signaling as a Translational Control Point
2026-09-03
SCH772984 HCl offers a precise way to interrogate ERK1/2 activity across oncogenic MAPK models and a complementary hypothalamic transcriptional system. This thought-leadership article connects pathway inhibition, adaptive resistance, genotype-aware assay design, and the context-dependent KLF4–Agrp axis while distinguishing established evidence from translational hypotheses.
-
Arachidonic Acid Accelerates Vaccine Humoral Immunity
2026-09-02
A 2025 EMBO Molecular Medicine study shows that dietary arachidonic acid can accelerate rabies vaccine-induced neutralizing antibody responses in mice and human volunteers. The work links arachidonic acid enrichment in lymph nodes to prostaglandin I2–cAMP–PKA signaling, CD86 expression, and activation-induced cytidine deaminase activity in B cells, defining a potential dietary strategy for faster humoral immunity.
-
Aminopeptidases and ACE Inhibitor Selectivity
2026-09-02
This reference study re-evaluated how bestatin, amastatin, probestin, actinonin, and several angiotensin converting enzyme inhibitors affect porcine kidney aminopeptidases A, N, and W. Its central contribution was to show that inhibitor selectivity is highly enzyme- and chemical-class-dependent, with some sulfhydryl ACE inhibitors unexpectedly inhibiting aminopeptidase W.